Rocio Ramos-Garcia

Madrid, MD 28040, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications

Depression and Mood Changes in People with Parkinson's Disease over Time: A 5-Year Follow-Up Study.

Depression and Mood Changes in People with Parkinson's Disease over Time: A 5-Year Follow-Up Study.

Journal: Journal of personalized medicine
Published: May 22, 2026

Sex Differences in the Treatment of People with Parkinson's Disease with a Device-Aided Therapy: A Prospective Real-World Study.

Sex Differences in the Treatment of People with Parkinson's Disease with a Device-Aided Therapy: A Prospective Real-World Study.

Journal: Medical sciences (Basel, Switzerland)
Published: March 28, 2026

Parkinson's disease-subjective cognitive decline and health-related quality of life.

Parkinson's disease-subjective cognitive decline and health-related quality of life.

Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: February 23, 2026

Quality of "on": a novel therapeutic objective in advanced Parkinson's disease.

Quality of "on": a novel therapeutic objective in advanced Parkinson's disease.

Journal: Parkinsonism & related disorders
Published: February 12, 2026

Verbal fluency in Parkinson's disease with mild cognitive impairment: quantitative, qualitative, and semantic network analyses.

Verbal fluency in Parkinson's disease with mild cognitive impairment: quantitative, qualitative, and semantic network analyses.

Journal: Parkinsonism & related disorders
Published: November 03, 2025

Correction: López-Manzanares et al. Real-World Use of COMT Inhibitors in the Management of Patients with Parkinson's Disease in Spain Who Present Early Motor Fluctuations: Interim Results from the REONPARK Study. Brain Sci. 2025, 15, 532.

Correction: López-Manzanares et al. Real-World Use of COMT Inhibitors in the Management of Patients with Parkinson's Disease in Spain Who Present Early Motor Fluctuations: Interim Results from the REONPARK Study. Brain Sci. 2025, 15, 532.

Journal: Brain sciences
Published: October 16, 2025

Impact of device-aided therapies on quality of life in patients with Parkinson's disease. A comparative multicenter observational study.

Impact of device-aided therapies on quality of life in patients with Parkinson's disease. A comparative multicenter observational study.

Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: September 23, 2025

Effects of levodopa-entacapone-carbidopa intrajejunal infusion on non-motor symptoms of advanced Parkinson's disease-interim analysis of the ELEGANCE study.

Effects of levodopa-entacapone-carbidopa intrajejunal infusion on non-motor symptoms of advanced Parkinson's disease-interim analysis of the ELEGANCE study.

Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: July 29, 2025

Real-World Use of COMT Inhibitors in the Management of Patients with Parkinson's Disease in Spain Who Present Early Motor Fluctuations: Interim Results from the REONPARK Study.

Real-World Use of COMT Inhibitors in the Management of Patients with Parkinson's Disease in Spain Who Present Early Motor Fluctuations: Interim Results from the REONPARK Study.

Journal: Brain sciences
Published: April 04, 2025

Profile of People With Parkinson's Disease Treated With a Device-Aided Therapy in Spain. A Comparative Multicenter Observational Study.

Profile of People With Parkinson's Disease Treated With a Device-Aided Therapy in Spain. A Comparative Multicenter Observational Study.

Journal: Movement disorders clinical practice
Published: March 04, 2025

Device-aided therapies (DATs) in Parkinson's disease (PD). The DATs-PD GETM Spanish Registry Protocol Study.

Device-aided therapies (DATs) in Parkinson's disease (PD). The DATs-PD GETM Spanish Registry Protocol Study.

Journal: PloS one
Published: December 04, 2024

Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson's Disease.

Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson's Disease.

Journal: Brain sciences
Published: October 22, 2024
Showing 1-12 of 59

Last Updated: 09/26/2026